{
  "ticker": "JNJ",
  "target_date": "2025-01-07",
  "actual_date": "2025-01-07",
  "collected_at": "2025-12-08T11:14:42.736642",
  "price": {
    "open": 139.49,
    "high": 142.81,
    "low": 139.33,
    "close": 141.88673400878906,
    "volume": 8422000,
    "change_1d_pct": 1.79,
    "change_7d_pct": 0.45,
    "change_30d_pct": -5.21
  },
  "technicals": {
    "rsi_14": 57.77,
    "sma_20": 141.14,
    "sma_50": 146.46,
    "macd": -1.842,
    "macd_signal": -2.197,
    "macd_histogram": 0.355,
    "bb_upper": 144.48,
    "bb_lower": 137.8,
    "price_vs_sma20_pct": 0.53,
    "price_vs_sma50_pct": -3.12,
    "volume_ratio": 1.03
  },
  "fundamentals": {
    "market_cap": 488870084608,
    "pe_ratio": 19.585909,
    "forward_pe": 19.142452,
    "price_to_book": 6.1586795,
    "price_to_sales": 5.3052135,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.36,
    "pct_from_52w_low": 44.24
  },
  "macro": {
    "spy": {
      "price": 583.52,
      "change_1d_pct": -1.13,
      "change_7d_pct": -1.07
    },
    "vix": {
      "level": 17.82,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.68
    },
    "dollar_index": {
      "level": 108.54
    },
    "gold": {
      "price": 2656.7
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors",
      "source": "Yahoo",
      "datetime": 1736289920,
      "summary": "Johnson & Johnson (JNJ) reachead $146.18 at the closing of the latest trading day, reflecting a +1.75% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=88b2876a8825a93f1d8073f34e8dfd0c2231d397e651fdedc128f6144ad5af48"
    },
    {
      "headline": "Johnson & Johnson: A Potential Beneficiary Of A Great Rotation",
      "source": "SeekingAlpha",
      "datetime": 1736288935,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0122879c251f0c90777fb899c0ef7d939d06da037118bdb5419b4c1792092d7f"
    },
    {
      "headline": "Top Research Reports for NVIDIA, Meta Platforms & Johnson & Johnson",
      "source": "Yahoo",
      "datetime": 1736273760,
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Meta Platforms, Inc. (META) and Johnson & Johnson (JNJ), as well as two micro-cap stocks Rave Restaurant Group, Inc. (RAVE) and EVI Industries, Inc. (EVI).",
      "url": "https://finnhub.io/api/news?id=0faecd9b53ec09fa25004cfd9f7d89ac7a64b70ac4b94ea2e7195553c93e47ba"
    },
    {
      "headline": "Johnson & Johnson stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1736267460,
      "summary": "Johnson & Johnson stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=cd1592ac05ca10d27185161dd8c69866e9dd4899738d2c61b657e8c741177d3c"
    },
    {
      "headline": "J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care",
      "source": "Yahoo",
      "datetime": 1736266474,
      "summary": "(Bloomberg) -- Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc\u2019s blockbuster Tagrisso in a head-to-head study, a finding that could change the standard of care for one of the most deadly tumor types.Most Read from BloombergNYC\u2019s Subway Violence Deters Driv",
      "url": "https://finnhub.io/api/news?id=bfa75fdc17fef8fb701a501bb45876c9b46329432fcee16b3e360d9610959204"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734042449.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000106/xslF345X05/wk-form4_1734042449.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041779.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000104/xslF345X05/wk-form4_1734041779.xml"
    },
    {
      "form": "4",
      "date": "2024-12-12",
      "description": "xslF345X05/wk-form4_1734041373.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000102/xslF345X05/wk-form4_1734041373.xml"
    },
    {
      "form": "13F-HR",
      "date": "2024-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445424000604/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "10-Q",
      "date": "2024-10-23",
      "description": "jnj-20240929.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/jnj-20240929.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}